参考文献/References:
[1]Nossent J, Cikes N, Kiss E, et al. Current causes of death in systemic lupus erythematosus in Europe, 2000—2004: relation to disease activity and damage accrual[J].Lupus,2007,16(5):309- 317.
[2]Li X, Qian Y, Liu N, et al. Survival rate, causes of death, and risk factors in systemic sclerosis:a large cohort study[J].Clin Rheumatol,2018,37(11): 3051-3056.
[3]Jia E, Geng H, Liu Q, et al. Cardiac manifestations of Han Chinese patients with systemic lupus erythematosus: a retrospective study[J].Ir J Med Sci, 2019;188(3): 801-806.
[4]Perez-Villa F, Font J, Azqueta M, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study[J].Arthritis Rheum,2005,53(3):460-467.
[5]Bourré-Tessier J, Huynh T, Clarke AE,et al. Features associated with cardiac abnormalities in systemic lupus erythematosus[J].Lupus, 2011,20(14):1518-1525.
[6]Shazzad MN, Islam MN, Ara R, et al. Echocardiographic assessment of cardiac involvement in systemic lupus erythematosus patients[J].Mymensingh Med J, 2013,22(4):736-741.
[7]Roldan CA, DeLong C, Qualls CR, et al. Characterization of valvular heart disease in rheumatoid arthritis by transesophageal echocardiography and clinical correlates[J].Am J Cardiol,2007,100(3):496-502.
[8]Guedes C, Bianchi-Fior P, Cormier B, et al. Cardiac manifestations of rheumatoid arthritis: a case-control transesophageal echocardiography study in 30 patients[J]. Arthritis Rheum,2001,45(2):129-135.
[9]Beckhauser AP, Vallin L, Burkievcz J, et al. Valvular involvement in patients with rheumatoid arthritis[J].Acta Reumatol Port,2009,34(1):52-56.
[10]Vassiliou VA, Moyssakis I, Boki KA, et al. Is the heart affected in primary Sjogren’s syndrome? An echocardiographic study[J].Clin Exp Rheumatol,2008, 26(1):109-112.
[11]Fernández-Codina A, Simeón-Aznar CP, Pinal-Fernandez I, et al. Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival[J].Rheumatol Int,2017,37(1):75-84.
[12]Nordin A, Svenungsson E, Bjornadal L, et al. Troponin I and echocardiography in patients with systemic sclerosis and matched population controls[J].Scand J Rheumatol,2017,46(3):226-235.
[13]Brunner F, Kunz A, Weber U, et al. Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15?years than in the normal population?[J].Clin Rheumatol, 2006,25(1):24-29.
[14]Klingberg E, Svealv BG, Tang MS, et al. Aortic regurgitation is common in ankylosing spondylitis:time for routine echocardiography evaluation?[J].Am J Med,2015,128(11):1244-1250.
[15]Ward MM. Lifetime risks of valvular heart disease and pacemaker use in patients with ankylosing spondylitis[J].J Am Heart Assoc,2018,7(20) :e010016.
[16]de Groote P, Gressin V, Hachulla E, et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis[J].Ann Rheum Dis,2008,67(1):31-36.
[17]Plazak W, Kopec G, Tomkiewicz-Pajak L, et al. Heart structure and function in patients with generalized autoimmune diseases: echocardiography with tissue Doppler study[J].Acta Cardiol,2011,66(2):159-165.
[18]Vivero F, Gonzalez-Echavarri C, Ruiz-Estevez B, et al. Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus[J]. Autoimmun Rev,2016,15(12):1134-1140.
[19]Sen D, González-Mayda M, Brasington RD. Cardiovascular Disease in Rheumatoid Arthritis[J]. Rheum Dis Clin N Am,2014,40(1):27-49.
[20]王春彬, 汪汉. 干燥综合征的心血管表现[J].心血管病学进展,2014,35(2): 233-236.
[21]林松柏, 谢洪智. 系统性硬化症心脏受累61例临床分析[J].中华心血管病杂志, 2009,37(6):525-527.
[22]Moyssakis I, Gialafos E, Vassiliou VA, et al. Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis[J].Scand J Rheumatol,2009,38(3):216-221.
[23]Kitas G, Banks MJ, Bacon PA. Cardiac involvement in rheumatoid disease[J]. Clin Med (Lond),2001,1(1):18-21.
[24]Chiang CH, Liu CJ, Chen PJ, et al. Primary sjogren’s syndrome and the risk of acute myocardial infarction: a nationwide study[J].Acta Cardiol Sin,2013, 29(2): 124-31.
[25]Foroughi M, Hekmat M, Ghorbani M, et al. Mitral valve surgery in patients with systemic lupus erythematosus[J]. ScientificWorldJournal, 2014,2014: 216291.
[26]Stulak JM, Suri RM, Matteson EL, et al. Mitral valve repair is durable in patients with rheumatoid arthritis[J].Ann Thorac Surg,2012,94(2):510-515.
[27]Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery[J].J. Am Coll Cardiol,2001,37(3):885-892.
[28]Miyagi N, Arai H. Aortic valve surgery for autoimmune disease[J].Kyobu Geka, 2012, 65(8):644-647.
相似文献/References:
[1]龙愉良,周达新.心脏瓣膜疾病介入治疗进展[J].心血管病学进展,2015,(5):542.[doi:10.3969/j.issn.1004-3934.2015.05.005]
LONG Yuliang,ZHOU Daxin.Progress of Interventional Therapy for Cardiac Valve Disease[J].Advances in Cardiovascular Diseases,2015,(9):542.[doi:10.3969/j.issn.1004-3934.2015.05.005]
[2]周力,李虹伟.结缔组织病并发冠状动脉性心脏病的危险因素[J].心血管病学进展,2015,(5):567.[doi:10.3969/j.issn.1004-3934.2015.05.011]
ZHOU Li,LI Hongwei.Risk Factors for Coronary Heart Disease in Connective Tissue Diseases[J].Advances in Cardiovascular Diseases,2015,(9):567.[doi:10.3969/j.issn.1004-3934.2015.05.011]
[3]刘古月 白文娟 唐红.实时三维经食管超声心动图对心脏瓣膜病的量化评估进展[J].心血管病学进展,2020,(10):1053.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.013]
LIU Guyue,BAI Wenjuan,TANG Hong.Developments in Real Time Three-Dimensional Transesophageal Echocardiography for Quantification of Valvular Heart Disease[J].Advances in Cardiovascular Diseases,2020,(9):1053.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.013]
[4]杨晓倩 张艺文 秦 莉 汪 汉.基于CiteSpace的结缔组织病相关肺动脉高压的文献分析[J].心血管病学进展,2021,(12):1129.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.018]
YANG Xiaoqian,ZHANG Yiwen,QIN Li,et al.Literature Analysis of Connective Tissue Disease-Related Pulmonary ArteriaHypertension Based on CiteSpace[J].Advances in Cardiovascular Diseases,2021,(9):1129.[doi:10.16806/j.cnki.issn.1004-3934.2021.12.018]
[5]杨子玄?刘圣?亢玉?张庆.新指标评估结缔组织病患者动脉僵硬度及其对左室舒张功能的影响[J].心血管病学进展,2022,(5):475.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.021]
YANG Zixuan,LIU Sheng,KANG Yu,et al.Arterial Stiffness Assessed by New Indices in Patients with Connective Tissue Disease and Their Association with Left Ventricular Diastolic Function[J].Advances in Cardiovascular Diseases,2022,(9):475.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.021]
[6]唐建辉 陈锋 汪汉.血清尿酸与结缔组织病[J].心血管病学进展,2022,(8):743.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.019]
TANG Jianhui,CHEN Feng,WANG Han?/html>.Serum Uric Acid and Connective Tissue Diseases[J].Advances in Cardiovascular Diseases,2022,(9):743.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.019]
[7]多力昆·木台力甫?阿布都赛米·艾尼 阿布都乃比·麦麦提艾力.青年女性患者心脏瓣膜的选择[J].心血管病学进展,2024,(6):489.[doi:10.16806/j.cnki.issn.1004-3934.202.06.003]
Duolikun·Mutailifu,Abudusaimi·Aini,Abudunaibi·Maimaitiaili.Duolikun·Mutailifu1,Abudusaimi·Aini1,Abudunaibi·Maimaitiaili2[J].Advances in Cardiovascular Diseases,2024,(9):489.[doi:10.16806/j.cnki.issn.1004-3934.202.06.003]